<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kishimoto D</submitter><funding>Yokohama Foundation for Advanced Medical Science</funding><funding>Naito Foundation</funding><funding>Japanese Society for the Promotion of Science Grants-in-Aid for Scientific Research</funding><funding>Takeda Medical Research Foundation</funding><funding>Japan Agency for Medical Research and Development</funding><funding>Japan Intractable Diseases Research Foundation</funding><funding>Japan Rheumatic Disease Foundation</funding><funding>Uehara Memorial Foundation</funding><funding>Mochida Memorial Foundation for Medical and Pharmaceutical Research</funding><funding>Japan Society for the Promotion of Science</funding><pagination>64</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5894134</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(1)</volume><pubmed_abstract>BACKGROUND:Innate immunity including macrophages (Mϕ) in lupus nephritis (LN) has been gaining attention, but roles of Mϕ in LN remain uncertain. METHODS:Immunohistochemical staining was performed to determine CD68, CD163, heme oxygenase (HO)-1 (a stress-inducible heme-degrading enzyme with anti-inflammatory property), pSTAT1, and CMAF-expressing Mϕ in the glomeruli of patients with LN. Effects of type I interferons on the expression levels of CD163, HO-1, BTB and CNC homology 1 (Bach1; a transcriptional HO-1 repressor), interleukin (IL)-6, and IL-10 by human M2-like Mϕ, which were differentiated in vitro from peripheral monocytes with macrophage colony-stimulating factor, were assessed by RT-PCR and immunocytostaining. Clinical manifestations, anti-double-stranded DNA (anti-dsDNA), and lo</pubmed_abstract><journal>Arthritis research &amp; therapy</journal><pubmed_title>Dysregulated heme oxygenase-1low M2-like macrophages augment lupus nephritis via Bach1 induced by type I interferons.</pubmed_title><pmcid>PMC5894134</pmcid><funding_grant_id>26860756</funding_grant_id><funding_grant_id>16K08698</funding_grant_id><funding_grant_id>7790011965</funding_grant_id><funding_grant_id>26461469</funding_grant_id><funding_grant_id>26461468</funding_grant_id><funding_grant_id>26713136</funding_grant_id><pubmed_authors>Nagahama K</pubmed_authors><pubmed_authors>Yoshimi R</pubmed_authors><pubmed_authors>Nakajima H</pubmed_authors><pubmed_authors>Kunishita Y</pubmed_authors><pubmed_authors>Kirino Y</pubmed_authors><pubmed_authors>Nakano H</pubmed_authors><pubmed_authors>Aoki I</pubmed_authors><pubmed_authors>Takeno M</pubmed_authors><pubmed_authors>Takase-Minegishi K</pubmed_authors><pubmed_authors>Kishimoto D</pubmed_authors><pubmed_authors>Igarashi K</pubmed_authors><pubmed_authors>Kato I</pubmed_authors><pubmed_authors>Tamura M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dysregulated heme oxygenase-1low M2-like macrophages augment lupus nephritis via Bach1 induced by type I interferons.</name><description>BACKGROUND:Innate immunity including macrophages (Mϕ) in lupus nephritis (LN) has been gaining attention, but roles of Mϕ in LN remain uncertain. METHODS:Immunohistochemical staining was performed to determine CD68, CD163, heme oxygenase (HO)-1 (a stress-inducible heme-degrading enzyme with anti-inflammatory property), pSTAT1, and CMAF-expressing Mϕ in the glomeruli of patients with LN. Effects of type I interferons on the expression levels of CD163, HO-1, BTB and CNC homology 1 (Bach1; a transcriptional HO-1 repressor), interleukin (IL)-6, and IL-10 by human M2-like Mϕ, which were differentiated in vitro from peripheral monocytes with macrophage colony-stimulating factor, were assessed by RT-PCR and immunocytostaining. Clinical manifestations, anti-double-stranded DNA (anti-dsDNA), and lo</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Apr</publication><modification>2025-04-26T06:58:46.54Z</modification><creation>2019-03-26T23:29:29Z</creation></dates><accession>S-EPMC5894134</accession><cross_references><pubmed>29636091</pubmed><doi>10.1186/s13075-018-1568-1</doi></cross_references></HashMap>